/* */ PELVIPHARM - SPECIALIZED PRECLINICAL EXPERTISE in male and female sexual functions and diseases of the lower urinary tract
Receive our news

 
NEWS

September 29th - 2011

Recently published paper in Eur Urol

Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG.
Eur Urol. 2011 Oct;60(4):809-25.

September 29th - 2011

Bio-Europe in Düsseldorf, October-November 2011

Pelvipharm will be represented by Delphine Behr-Roussel at the next Bio-Europe meeting in Düsseldorf, October 31 - November 2, 2011. We warmly invite you to take this opportunity to learn more about our services.

If you’d like to set up a specific meeting at any time throughout the conference, please email staffpelvipharm@pelvipharm.com and we will be happy to assist you.

 Bio_Europe_Nov_2011.jpg

 

September 29th - 2011

Recently published paper in Int J Clin Pract

Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.
Mirone V, Sessa A, Giuliano F, Berges R, Kirby M, Moncada I.
Int J Clin Pract. 2011 Sep;65(9):1005-13.

September 26th - 2011

Recently published paper in Eur Urol

Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence.
Martínez-Salamanca JI, Carballido J, Eardley I, Giuliano F, Gratzke C, Rosen R, Salonia A, Stief C.
Eur Urol. 2011 Sep; 60(3):527-35.

September 15th - 2011

Recent paper highlighted in Eur Urol editorial

Recently accepted paper in European Urology (Combination of BAY 60-4552 and vardenafil exerts proerectile facilitator effects in rats with cavernous nerve injury: A proof of concept study for the treatment of PDE5 inhibitor failure. Oudot A., Behr-Roussel D., Poirier S., Sandner P., Bernabé J., Alexandre L., Giuliano F. (Eur. Urol. Available online July 30th 2011, in press) is published as a Platinium Priority and highlighted by an editorial written by an expert in this field, Pr V. Mirone.

Pr V. Mirone stated in this editorial that “the animal model used in this study perfectly represents the type of lesion that usually occurs during a nerve-sparing radical prostatectomy procedure” and that the results “completely concur with the partial clinical response to PDE5 inhibitors routinely observed in patients who underwent a nerve-sparing radical prostatectomy”. The novelty of this study is also emphasized: “The results of the study by Oudot et al. no doubt point us in the right direction to manage ED difficult patients more effectively” (Eur. Urol. Available online August 16th 2011).

August 31st - 2011

Recently published paper in BJU Int

Effects of potassium channel modulators on myogenic spontaneous phasic contractile activity in human detrusor from neurogenic patients.
Oger S, Behr-Roussel D, Gorny D, Bernabé J, Comperat E, Chartier-Kastler E, Denys P, Giuliano F.
BJU Int - (2011 Aug) : 108(4):604-11

Page 9 / 19     Previous      1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  Next 
SITEMAP
TEL +331 704 293 39
FAX + 331 704 295 10
LEGAL